CORRECTION article

Front. Pharmacol., 12 April 2023

Sec. Pharmacology of Anti-Cancer Drugs

Volume 14 - 2023 | https://doi.org/10.3389/fphar.2023.1200491

Corrigendum: Adenosine kinase on deoxyribonucleic acid methylation: Adenosine receptor-independent pathway in cancer therapy

  • 1. Department of Gastrointestinal and Anorectal Surgery, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China

  • 2. Department of Neuroscience, Legacy Research Institute, Portland, OR, United States

  • 3. Integrative Physiology and Neuroscience, Washington State University, Vancouver, WA, United States

  • 4. Legacy Tumor Bank, Legacy Research Institute, Portland, OR, United States

  • 5. Mid-Columbia Medical Center, The Dalles, OR, United States

In the published article, there was an error in the Affiliation for Authors Hao-Yun Luo and Ya-Xu Wang. Instead of “1Chongqing Medical University, Chongqing, China, 2Department of Gastrointestinal and Anorectal Surgery, The Second Affiliated Hospital of Chongqing Medical University, Chongqing Medical University, Chongqing, China”, the correct affiliation is “1Department of Gastrointestinal and Anorectal Surgery, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China”.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Statements

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Summary

Keywords

DNA methylation, adenosine, receptor-independent pathway, adenosine kinase, ADK isoforms, ADK inhibitor, cancer therapy

Citation

Luo H-Y, Shen H-Y, Perkins RS and Wang Y-X (2023) Corrigendum: Adenosine kinase on deoxyribonucleic acid methylation: Adenosine receptor-independent pathway in cancer therapy. Front. Pharmacol. 14:1200491. doi: 10.3389/fphar.2023.1200491

Received

05 April 2023

Accepted

06 April 2023

Published

12 April 2023

Approved by

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Volume

14 - 2023

Updates

Copyright

*Correspondence: Ya-Xu Wang,

†These authors have contributed equally to this work

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Outline

Cite article

Copy to clipboard


Export citation file


Share article

Article metrics